Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Veronika Schneider, Karin M. Cabanillas Stanchi, Karina Althaus, Sarah Schober, Sebastian Michaelis, Christian Seitz, Peter Lang, Rupert Handgretinger, Tamam Bakchoul, Stefanie Hammer & Michaela Döring. (2023) Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation. Journal of Cancer Research and Clinical Oncology 149:11, pages 8443-8453.
Crossref
Crossref
Carmen De Ramón Ortiz, Raul Justo Sanz, Yan Beauverd, Karem Humala, Ana López de la Guia, Raquel De Paz, Mercedes Gasior, Pilar Gómez Prieto, Marta Fabra Urdiola, Miguel Canales Albendea, Nora Butta & Victor Jiménez Yuste. (2023) Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation. Disease Markers 2023, pages 1-9.
Crossref
Crossref
Paul G. Richardson, Marta Palomo, Nancy A. Kernan, Gerhard C. Hildebrandt, Nelson Chao & Enric Carreras. (2021) The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae. Bone Marrow Transplantation 56:12, pages 2889-2896.
Crossref
Crossref
Atsushi Kikuta. (2021) Treatment of Sinusoidal obstruction syndrome (Veno-occlusive disease)肝中心静脈閉塞症(SOS/VOD)の治療. Journal of Hematopoietic Cell Transplantation 10:1, pages 36-47.
Crossref
Crossref
Christian Schoergenhofer, Nina Buchtele, Georg Gelbenegger, Ulla Derhaschnig, Christa Firbas, Katarina D. Kovacevic, Michael Schwameis, Philipp Wohlfarth, Werner Rabitsch & Bernd Jilma. (2019) Defibrotide enhances fibrinolysis in human endotoxemia – a randomized, double blind, crossover trial in healthy volunteers. Scientific Reports 9:1.
Crossref
Crossref
Mairéad Ní Chonghaile & Karen Wolownik. (2018) Identification and Management: Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Eelated to Hematopoietic Stem Cell Transplantation
. Clinical Journal of Oncology Nursing 22:1, pages E7-E17.
Crossref
Crossref
Valerie I. Brown. 2018. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist
215
233
.
Joanna Rupa-Matysek, Lidia Gil, Ewelina Wojtasińska, Zuzanna Kanduła, Adam Nowicki, Magdalena Matuszak & Mieczysław Komarnicki. (2017) Evaluation of thromboelastometry parameters as predictive markers for sinusoidal obstruction syndrome in patients undergoing allogeneic stem cell transplantation for acute leukaemia. Oncotarget 8:35, pages 60001-60014.
Crossref
Crossref
Takashi Ishihara, Keiji Nogami, Tomoko Matsumoto, Akitaka Nomura, Yasufumi Takeshita, Satoshi Ochi & Midori Shima. (2017) Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation. International Journal of Hematology 106:1, pages 126-134.
Crossref
Crossref
Jiaqi Zhang, Yuchen Sheng, Liang Shi, Zhiyong Zheng, Minwei Chen, Bin Lu & Lili Ji. (2017) Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats. European Journal of Pharmacology 795, pages 160-168.
Crossref
Crossref
Zhiyong Zheng, Liang Shi, Yuchen Sheng, Jiaqi Zhang, Bin Lu & Lili Ji. (2016) Chlorogenic acid suppresses monocrotaline-induced sinusoidal obstruction syndrome: The potential contribution of NFκB, Egr1, Nrf2, MAPKs and PI3K signals. Environmental Toxicology and Pharmacology 46, pages 80-89.
Crossref
Crossref
M Mohty, F Malard, M Abecassis, E Aerts, A S Alaskar, M Aljurf, M Arat, P Bader, F Baron, A Bazarbachi, D Blaise, F Ciceri, S Corbacioglu, J-H Dalle, F Dignan, T Fukuda, A Huynh, T Masszi, M Michallet, A Nagler, M NiChonghaile, S Okamoto, A Pagliuca, C Peters, F B Petersen, P G Richardson, T Ruutu, B N Savani, E Wallhult, I Yakoub-Agha, R F Duarte & E Carreras. (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation 51:7, pages 906-912.
Crossref
Crossref
Atsushi Kikuta & Kimikazu Yakushijin. (2016) Diagnosis and Treatment of Sinusoidal obstruction syndrome (Veno-occlusive disease) after Haematopoietic cell transplantation. Journal of Hematopoietic Cell Transplantation 5:4, pages 124-137.
Crossref
Crossref
Brandon M. Triplett, Hani I. Kuttab, Guolian Kang & Wing Leung. (2015) Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive Disease. Biology of Blood and Marrow Transplantation 21:12, pages 2148-2153.
Crossref
Crossref
HONG CHEN, XU WANG, TIEYAN FAN, JUN LI, LETIAN WANG & ZHONGYANG SHEN. (2014) A case of veno-occlusive disease following liver transplantation. Experimental and Therapeutic Medicine 7:1, pages 141-144.
Crossref
Crossref
Fiona L. Dignan, Robert F. Wynn, Nedim Hadzic, John Karani, Alberto Quaglia, Antonio Pagliuca, Paul Veys & Michael N. Potter. (2013) BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. British Journal of Haematology 163:4, pages 444-457.
Crossref
Crossref
S M Robinson, D A Mann, D M Manas, F Oakley, J Mann & S A White. (2013) The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome. British Journal of Cancer 109:9, pages 2396-2403.
Crossref
Crossref
Janka Reimer, Sandra Bien, Sabine Ameling, Elke Hammer, Uwe Völker, Georg Hempel, Joachim Boos, Heyo K. Kroemer & Christoph A. Ritter. (2012) Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis. European Journal of Clinical Pharmacology 68:6, pages 923-935.
Crossref
Crossref
Maria Giuseppina Cefalo, Palma Maurizi, Annalisa Arlotta, Maria Scalzone, Giorgio Attinà, Antonio Ruggiero & Riccardo Riccardi. (2010) Hepatic Veno-Occlusive Disease. Pediatric Drugs 12:5, pages 277-284.
Crossref
Crossref
Corey Cutler, Haesook T. Kim, Shaké Ayanian, Gary Bradwin, Carolyn Revta, Julie Aldridge, Vincent Ho, Edwin Alyea, John Koreth, Philippe Armand, Robert Soiffer, Jerome Ritz, Paul G. Richardson & Joseph H. Antin. (2010) Prediction of Veno-Occlusive Disease Using Biomarkers of Endothelial Injury. Biology of Blood and Marrow Transplantation 16:8, pages 1180-1185.
Crossref
Crossref
Amber A. Petrolla, Hillard M. Lazarus & Alvin H. Schmaier. 2010. Allogeneic Stem Cell Transplantation. Allogeneic Stem Cell Transplantation
695
715
.
Cinara L Echart, Barbara Graziadio, Simona Somaini, Laura I Ferro, Paul G Richardson, Jawed Fareed & Massimo Iacobelli. (2009) The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity. Blood Coagulation & Fibrinolysis 20:8, pages 627-634.
Crossref
Crossref
Dimitrios A. Tsakiris & André Tichelli. (2009) Thrombotic complications after haematopoietic stem cell transplantation: early and late effects. Best Practice & Research Clinical Haematology 22:1, pages 137-145.
Crossref
Crossref
Leonardo R. Brandão, Morris Kletzel, Farid Boulad, Joanne Kurtzberg, Kelly Maloney, Igal Fligman, Cristina P. Sison & Donna DiMichele. (2008) A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation. Pediatric Blood & Cancer 50:6, pages 1240-1246.
Crossref
Crossref
M C Bunte, M M Patnaik, M R Pritzker & L J Burns. (2008) Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone Marrow Transplantation 41:8, pages 677-686.
Crossref
Crossref
S. W. Eber, T. Gungor, A. Veldman, K. Sykora, F. Scherer, D. Fischer & L. Grigull. (2007) Favorable response of pediatric stem cell recipients to human protein C concentrate substitution for veno-occlusive disease. Pediatric Transplantation 11:1, pages 49-57.
Crossref
Crossref
A. HELMY. (2006) Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Alimentary Pharmacology and Therapeutics 23:1, pages 11-25.
Crossref
Crossref
Salih Aksu, Yavuz Beyazit, Ibrahim C Haznedaroglu, Hakan Goker, Murat Kekilli, Jale Karakaya, Ebru Koca, Deniz Cetiner, Nilgün Sayinalp, Yahya Buyukasik, Osman I Ozcebe, Serafettin Kirazli & Semra V Dundar. (2006) Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation. Blood Coagulation & Fibrinolysis 17:1, pages 47-51.
Crossref
Crossref
Maged I. Gharib, Sean R. Bulley, John J. Doyle & Robert F. Wynn. (2006) Venous occlusive disease in children. Thrombosis Research 118:1, pages 27-38.
Crossref
Crossref
Maria Teresa Sartori, Luca Spiezia, Simone Cesaro, Chiara Messina, Myriam Paris, Marta Pillon, Graziella Saggiorato, Antonio Pagnan, Antonio Girolami, Luigi Zanesco & Giuseppe Cella. (2018) Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population. Thrombosis and Haemostasis 93:04, pages 682-689.
Crossref
Crossref
G Eissner, M Iacobelli, S Blüml, V Burger, S Haffner, R Andreesen & E Holler. (2005) Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity. Bone Marrow Transplantation 35:9, pages 915-920.
Crossref
Crossref
Hugo E. Vargas & Thomas D. Boyer. 2005. Portal Hypertension. Portal Hypertension
433
453
.